| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA680582 | F | In vitro cytotoxicity was determined against IGROVI human ovarian cell line using NCI screen | Homo sapiens | 1 | ALA1124780 | cell-based format | Scientific Literature | |
| 2. | ALA696001 | F | In vitro inhibition of Jurkat cell apoptosis at 10 uM of compound | Homo sapiens | 7 | ALA1134769 | cell-based format | Scientific Literature | |
| 3. | ALA696002 | F | In vitro inhibition of Jurkat cell apoptosis at 50 uM of compound | Homo sapiens | 7 | ALA1134769 | cell-based format | Scientific Literature | |
| 4. | ALA700889 | F | Compound was evaluated for the growth inhibition of IGOV1 ovarian cell lines | Homo sapiens | 4 | ALA1133028 | cell-based format | Scientific Literature | |
| 5. | ALA701512 | F | In vitro cytotoxicity against Ovary IGROVIg OVI human tumors following a 2 day exposure. | Homo sapiens | 7 | ALA1131966 | cell-based format | Scientific Literature | |
| 6. | ALA701513 | F | In vitro cytotoxicity against Ovary IGROVIg OVI human tumors following a 2 day exposure; ND is no data | Homo sapiens | 1 | ALA1131966 | cell-based format | Scientific Literature | |
| 7. | ALA701517 | F | Cytotoxicity against IGROV Tumor cell line in SRB Cell viability test | Homo sapiens | 6 | ALA1132947 | cell-based format | Scientific Literature | |
| 8. | ALA701518 | F | In vitro antiproliferative activity against human IGROV ovarian cell line | Homo sapiens | 10 | ALA1148478 | cell-based format | Scientific Literature | |
| 9. | ALA701519 | F | Antiproliferative activity of compound was tested against ovarian carcinoma (IGROV) human tumor cells | Homo sapiens | 3 | ALA1128100 | cell-based format | Scientific Literature | |
| 10. | ALA701520 | F | In vitro cytotoxicity against human tumor IGROV cell line (ovarian cancer) | Homo sapiens | 5 | ALA1136742 | cell-based format | Scientific Literature | |
| 11. | ALA879051 | F | Cytotoxicity against IGROV tumor cell line | Homo sapiens | 5 | ALA1132544 | cell-based format | Scientific Literature | |
| 12. | ALA702692 | F | In vitro antitumor activity against IGROV human cancer cell line | Homo sapiens | 8 | ALA1135095 | cell-based format | Scientific Literature | |
| 13. | ALA702693 | F | In vitro antitumor activity against IGROV human cancer cell line (Data from NCI-screening) | Homo sapiens | 4 | ALA1135095 | cell-based format | Scientific Literature | |
| 14. | ALA702694 | F | Inhibitory dose required against IGROV human tumor cell lines | Homo sapiens | 4 | ALA1134893 | cell-based format | Scientific Literature | |
| 15. | ALA702695 | F | Antitumor activity against IGROVI cell line | Homo sapiens | 4 | ALA1127500 | cell-based format | Scientific Literature | |
| 16. | ALA702696 | F | Apoptosis was determined my morphological analysis of propidium-iodide-stained cells following 24 hr exposure to IC80 (0.5 uM), value expressed as percentage of apoptotic cells versus total cell number | Homo sapiens | 2 | ALA1136723 | cell-based format | Scientific Literature | |
| 17. | ALA699963 | F | Apoptosis was determined my morphological analysis of propidium-iodide-stained cells following 48 hr exposure to IC80 (0.5 uM), value expressed as percentage of apoptotic cells versus total cell number | Homo sapiens | 2 | ALA1136723 | cell-based format | Scientific Literature | |
| 18. | ALA699964 | F | Apoptosis was determined my morphological analysis of propidium-iodide-stained cells following 72 hr exposure to IC80 (0.5 uM), value expressed as percentage of apoptotic cells versus total cell number | Homo sapiens | 2 | ALA1136723 | cell-based format | Scientific Literature | |
| 19. | ALA699965 | F | Tested in vitro for cytotoxicity in IGROV1 cell lines | Homo sapiens | 14 | ALA1127574 | cell-based format | Scientific Literature | |
| 20. | ALA699966 | F | Antiproliferative effect of compound on IGROV-1 cell line expressing wild-type p53 | Homo sapiens | 2 | ALA1136723 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!